Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Memorial Day Weekend Brings Severe Storms, Tornado Risk, Scorching Heat And Hurricane-Force Winds—Here’s What To Expect In Your Region
There were 22% fewer people with kidney-related problems among the nearly 9,000-strong cohort taking weekly semaglutide injections compared to the group receiving a placebo, the researchers found, a relative incidence of 1.8% and 2.2%, respectively. Semaglutide’s ability to tackle this last condition, the onset of macroalbuminuria, is likely a key factor in reducing the chance of kidney-related complications, the researchers said.
Diabetes Weight Loss Obesity Novo Nordisk Eli Lilly Ozempic Wegovy Semaglutide
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Weight loss wonder drug sparks 'Ozempic babies' phenomenonA new phenomenon of women having surprise pregnancies while taking weight loss medications like Ozempic and Wegovy is happening.
Read more »
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug PricesRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »